Zidovudine-induced anaemia in HIV/AIDS

Indian Journal of Medical Research

Volumn 132, Issue 10, 2010, Pages 359-361

  Sharma, Surendra K ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; EFAVIRENZ; EMTRICITABINE; HEMOGLOBIN; LAMIVUDINE; NEVIRAPINE; STAVUDINE; TENOFOVIR; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANEMIA; ANTIVIRAL THERAPY; ARTICLE; BLOOD SMEAR; BLOOD TOXICITY; BONE MARROW TOXICITY; COMBINATION CHEMOTHERAPY; DRUG INDUCED DISEASE; DRUG MONITORING; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FATIGUE; HEMOGLOBIN BLOOD LEVEL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; MITOCHONDRIAL TOXICITY; NORMOCHROMIC NORMOCYTIC ANEMIA; RETROSPECTIVE STUDY; TUBERCULOSIS; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; METABOLISM; MYELOID PROGENITOR CELL; NOTE; SEX DIFFERENCE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANEMIA; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HEMOGLOBINS; HUMANS; INDIA; MYELOID PROGENITOR CELLS; SEX FACTORS; ZIDOVUDINE;

EID: 78049472055     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Miles SA. Hematopoietic growth factors as adjuncts to.antiretroviral therapy. AIDS Res Hum Retroviruses 1992;8:1073-1080.
2. Belperio PS, Rhew DC. Prevalence and outcomes of anemia in. individuals with human immunodeficiency virus: a systematic review of the literature. Am J Med 2004;116 (Suppl 7A):27S-43S.
3. Barroso J. A review of fatigue in people with HIV infection. J Assoc Nurses AIDS Care 1999;10:42-49.
4. Revicki DA, Brown RE, Henry DH, McNeill MV, Rios A, Watson A, et al. Recombinant human erythropoietin and health-related quality of life of AIDS patients with anemia. J Acquir Immune Defic Syndr 1994;7:474-484.
5. Semba RD, Gray G.E. Pathogenesis of anemia during human immunodeficiency virus infection. J Invest Med 2001;49:225-239.
6. Sullivan PS, Hanson DL, Chu SY, Jones JL, Ward JW. Epidemiology of anemia in human immunodeficiency virus (HIV)-infected persons: results from the multistate adult and adolescent spectrum of HIV disease surveillance project. Blood 1998;91:301-308.
7. Mocroft A, Kirk O, Barton SE, Dietrich M, Proenca R, Colebunders R, et al. Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. EuroSIDA Study Group. AIDS 1999;13:943-950.
8. Lundgren JD, Mocroft A. Anemia and survival in human immunodeficiency virus. Clin Infect Dis 2003;37 (Suppl 4):S297-S303.
9. Spivak JL. The blood in systemic disorders. Lancet 2000;355: 1707-1712.
10. Kreuzer KA, Rockstroh JK, Jelkmann W, Theisen A, Spengler U, Sauerbruch T, et al. Inadequate erythropoietin response to anemia in HIV patients: relationship to serum levels of tumor necrosis factor-alpha, interleukin-6 and their soluble receptors. Br J Haematol 1997;96:235-239.
11. Groopman JE. Zidovudine intolerance. Rev Infect Dis 1990;12 (Suppl 5):S500-S506.
12. Hassan A, Babadoko AA, Mamman AI, Ahmed SA. Zidovudine induced pure red cell aplasia: a case report. Niger J Med 2009;18:332-333.
13. Weinkove R, Rangarajan S, van der Walt J, Kulasegaram R. Zidovudine-induced pure red cell aplasia presenting after 4 years of therapy. AIDS 2005;19:2046-2047.
14. Guidelines on co-trimoxazole prophylaxis for HIV-related infections among children, adolescents and adults in resource-limited settings: recommendations for a public health approach. Geneva: World Health Organization; 2006.
15. Agarwal D, Chakravarty J, Chaube L, Rai M, Agrawal NR, Sundar S. High incidence of zidovudine induced anaemia in HIV infected patients in eastern India. Indian J Med Res 2010;132: 386-389.
16. Kumarasamy N, Venkatesh KK, Cecelia AJ, Devaleenal B, Lai AR, Saghayam S, et al. Spectrum of adverse events after generic HAART in southern Indian HIV-infected patients. AIDS Patient Care STDS 2008;22:337-344.
17. World Health Organization. Rapid advice. Antiretroviral therapy for HIV infection in adults and adolescents. Geneva: WHO; 2009.